Essenlix
Essenlix Corporation is a digital health and wellness company developing the iMOST (Instant Mobile Self-Test) platform, a revolutionary mobile health self-test device that enables users to perform accurate diagnostic tests anywhere, anytime, using a single drop of body fluid and a portable device. The platform is designed to be fault tolerant and versatile, supporting multiple sample types, assays, and biomarkers through advanced nanotechnology, imaging, and AI/ML. Essenlix's first product, iMOST-CBC, offers complete blood count testing and is CE Mark cleared, with plans for FDA approval. The company aims to replace conventional lab tests with instant mobile self-tests, facilitating remote health monitoring and e-health services globally.
Essenlix
Essenlix Corporation is a digital health and wellness company developing the iMOST (Instant Mobile Self-Test) platform, a revolutionary mobile health self-test device that enables users to perform accurate diagnostic tests anywhere, anytime, using a single drop of body fluid and a portable device. The platform is designed to be fault tolerant and versatile, supporting multiple sample types, assays, and biomarkers through advanced nanotechnology, imaging, and AI/ML. Essenlix's first product, iMOST-CBC, offers complete blood count testing and is CE Mark cleared, with plans for FDA approval. The company aims to replace conventional lab tests with instant mobile self-tests, facilitating remote health monitoring and e-health services globally.